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PorinBurkholderia pseudomallei (Bps) is a Gram-negative bacterium that causes melioidosis, an infectious disease of
animals and humans common in northern and north-eastern parts of Thailand. Successful treatment of
melioidosis is difﬁcult due to intrinsic resistance of Bps to various antibacterial agents. It has been suggested that
the antimicrobial resistance of this organismmay result frompoorpermeability of the active compounds through
porin channels located in the outermembrane (OM)of the bacterium. In previouswork, a 38-kDaprotein, named
“BpsOmp38”, was isolated from theOMof Bps. A topology prediction and liposome-swelling assay suggested that
BpsOmp38 comprises aβ-barrel structure and acts as a general diffusion porin. The present study employed black
lipidmembrane (BLM) reconstitution to demonstrate the single-channel conductance of the trimeric BpsOmp38
to be 2.7±0.3 nS in 1 M KCl. High-time resolution BLMmeasurements displayed ion current blockages of seven
antimicrobial agents in a concentration-dependent manner with the translocation on-rate (kon) following the
order: norﬂoxacin≫ertapenemNceftazidimeNcefepimeN imipenemNmeropenemNpenicillinG. The dwell time
of a selected antimicrobial agent (ertapenem) decayed exponentially with increasing temperature. The energy
barrier for the ertapenem binding to the afﬁnity site inside the BpsOmp38 channel was estimated from the
Arrhenius plot to be 12 kT and for the ertapenem release to be 13 kT at +100 mV. The BLM data obtained from
this study provide the ﬁrst insight into antimicrobial agent translocation through the BpsOmp38 channel.ingart@jacobs-university.de
IB Swiss Institute of Bioinfor-
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Burkholderia pseudomallei (Bps) is a soil-dwelling Gram-negative
bacterium commonly found in Southeast Asia and Northern Australia
and a cause of a deadly disease of mammalian species termed mel-
ioidosis [1–4]. Patients infected with Bps usually develop skin ulcers,
visceral abscesses, pneumonia and septicemia that imperatively
require immediate antimicrobial treatment to avoid fatal progression
of the disease. Very often, antimicrobial treatment is quite a chal-
lenge due to the high intrinsic broad spectrum resistance that most
Bps strains exhibit towards a broad spectrum of antimicrobial agents
including but not limited to β-lactam antibiotics, aminoglycosides,
macrolides, and cephalosporins [1–4]. Due to the high incidence of
drug resistance and very high virulence, Bps is regarded a potential
bioterrorism and warfare agent [5]. As such, this organism has been
listed by the US Centre for Disease Control and Prevention as acategory B health hazard [6,7]. Clinical and security concerns asso-
ciated with Bps have justiﬁed intensive research in attempt to address
the structural and functional organization of this pathogen as a
prelude to the design of novel and efﬁcacious anti-Bps therapeutic
agents. Most of ongoing studies include characterization of biological
and pathophysiological aspects of the agent, unraveling the mecha-
nisms of genomic plasticity and evolution, as well as understanding
the molecular mechanisms underlying drug resistance. The publica-
tion of the sequences of the entire Bps genome [8], as well as data from
drug susceptibility testing [9–12], and recent reports on Bps vaccines
[13–15] are important developments in the search for an effective
anti-melioidosis treatment.
Current scientiﬁc evidence suggests that Bps successfully utilizes the
strategy of genetic evolution, modiﬁed protein expression and/or
mutation more than most other bacteria. These features underscore
the ability of the pathogen to establish troublesome resistance against
many antimicrobial agents. Some of the mechanisms of drug resis-
tance include: alteration of intracellular drug action sites, generation of
enzymes for the modiﬁcation and/or complete degradation of drug
molecules within the cytosol, and restriction of intracellular drug
accumulation through impaired uptake and/or enhanced drug efﬂux
[16–19].
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uptake which in a number of other bacteria is associated with
reduced molecular transport of the active compounds through
bacterial outer membrane protein (Omp) channels. Also known as
porins, Omp channels are typical β-barrel protein structures that
independently or as oligomeric units are inserted into the outer lipid
bilayer of the bacterial cell wall to form pores through which
extracellular species can diffuse and gain access to the periplasmic
space and cytosol [20–22]. Membrane trafﬁcking via porins has
been elegantly measured at molecular level using the black lipid
membrane (BLM) technique [23–25]. In BLM experiments, the
parameter measured is the voltage-induced charge ﬂow through an
artiﬁcial lipid bilayer membrane that separates two electrolyte
compartments and one that has the study porin artiﬁcially inserted.
Recordings of the transmembrane current at microsecond time
resolution enable visualization of insertions of the porin in their open
state as stepwise increases in the signal. Movement of individual
drug/other molecules through a stably open unit is detected by
means of transient current ﬂuctuations derived from physical
channel blockade during the residence time of compounds traveling
through the porin. Mechanistically, bacterial cells can counteract the
inﬂux of drug molecules through reduction of the total number of
porins in their outer membrane, a decrease in the cross-sectional
dimension of the protein channels, and/or through modiﬁcation of
the electrostatics and/or hydrophobicity of the pore interior through
point mutations of the amino acids lining the protein pores. Quan-
titative correlation of the entry of speciﬁc drug molecules with a
ﬁrm structural and predictive computational analysis may lead to a
better understanding of the molecular basis of antimicrobial agent
permeability, facilitating the design of effective drugs that have
greater penetrating power [26].
While functional [27–32] and computational [33–35] BLM studies
focused on membrane drug permeation have been performed on
a number of bacterial porins, no similar research has investigated
analogous proteins from clinically important Bps strains. In previous
work, an Omp with an apparent molecular weight (MW) of
38 kDa, referred to as BpsOmp38, was isolated from the Bps cell
wall [36,37]. Topology prediction and molecular modeling suggested
that BpsOmp38 has a β-barrel structure, a feature that is common
among membrane porins. Subsequently, a liposome-swelling assay
on this protein conﬁrmed its channel-forming properties [37]. In
the present study, a detailed functional characterization of the
BpsOmp38 porin by BLM-based single ion-channel analysis is
described. Ion currentmeasurementswere carried out in the absence
and in the presence of seven different antimicrobial agents as addi-
tional diffusing species in the membrane-bathing electrolyte. The
differences in the ability of the selected drugs to move through
open BpsOmp38 pores and their kinetic behavior are discussed in the
context of molecular drug/porin interactions.
2. Materials and methods
2.1. BpsOmp38 expression and puriﬁcation
The E. coli strain BL21 (DE3) Omp8 was a gift from Ralf Koebnik,
Laboratoire Génome et Développement des Plantes, Universit é de
Perpignan via Domitia, Montpellier, France. This strain of E. coli does
not express the major outer membrane proteins LamB, OmpA, OmpC
and OmpF [38]; it was experimentally transformed with the recom-
binant plasmid pET23d.BpsOmp38. Puriﬁcation of the recombinant
BpsOmp38 followed a modiﬁed version of protocols described by
Garavito and Rosenbusch [39] and Rosenbusch [40]. In brief, trans-
formed cells were grown at 37 °C in Luria–Bertani (LB) liquid medium
containing 100 μg/ml ampicillin. At an OD600 reading of 0.5, IPTG
(isopropyl β-D-thiogalactoside) was added to a ﬁnal concentration of
0.4 mM. Cell growth was continued for a further 6 h and then cellswere harvested by centrifugation at 2948×g for 10 min. The cell pellet
was resuspended in buffer containing 20 mM Tris–HCl, pH 8.0,
2.5 mM MgCl2, 0.1 mM CaCl2, 10 μg/ml DNase I and 10 μg/ml RNase
A and then disrupted using a high-pressure homogenizer (Emulsi-
Flex-C3, Avestin Europe, Mannheim, Germany). The recombinant
BpsOmp38 was further extracted from the peptidoglycan layer using
sodium dodecyl sulfate (SDS)-containing solutions based on a
procedure reported by Lugtenberg and Alphen [41]. Brieﬂy, SDS was
added to the cell suspension to a ﬁnal concentration of 2% (v/v) and
incubation was carried out for 1 h at 60 °C with gentle shaking. The
crude extract was then centrifuged at 39,636×g for 60 min at 4 °C.
The pellet, which at this stage included the cell envelopes, was
resuspended in 20 mM phosphate buffer, pH 7.4 (PBS), containing
0.125% (v/v) octyl-POE (n-octyl-polyoxyethylene; ALEXIS Biochem-
icals, Lausanne, Switzerland). The suspension was incubated at 37 °C
with gentle shaking for 60 min and then centrifuged at 109,564×g at
4 °C for 40 min. The new pellet, now rich in outer membranes, was
resuspended in 20 mM phosphate buffer, pH 7.4 containing 3% (v/v)
octyl-POE and the suspension incubated at 37 °C with shaking at
250 rpm for 1 h to solubilize the porin. Insoluble material was
removed by centrifugation at 109,564×g at 20 °C for 40 min and
the porin-rich supernatant concentrated using Amicon Ultra-15
centrifugal ﬁlter devices with a nominal MW limit of 30 kDa
(Millipore, Schwalbach, Germany). Amicon centrifugal ﬁlters were
also used to exchange the original preparation buffer with 20 mMPBS,
containing 1% (v/v) octyl-POE. Aliquots of the ﬁnal protein sample
were used for absorbance measurement at 280 nm for the determi-
nation of protein concentration using NanoDropT 1000 Spectropho-
tometer (Thermo Fisher Scientiﬁc,Wilmington, DE, USA) and for SDS–
polyacrylamide gel electrophoresis (SDS–PAGE) for the assessment
of sample purity.
2.2. Lipid bilayer measurements and single-channel analysis
The following chemicals were used: NaCl, KCl, MES, n-pentane,
and hexadecane (Sigma-Aldrich, Hamburg, Germany); ceftazidime,
norﬂoxacin, and penicillin G (Sigma-Aldrich); cefepime, imipenem,
meropenem, and ertapenem (Basilea Pharmaceutica Ltd., Basel,
Switzerland); and 1,2-diphytanoyl-sn-glycero-3-phosphatidylcholine
(DPhPC) (Avanti Polar Lipids, Alabaster, AL, USA). Double distilled and
deionized water was used to prepare chemical reagents and the
freshly made solutions passed through a 0.4-μm ﬁlter. The drug stock
solutions for translocation experiments were prepared with 1 M KCl
in electrolyte buffer (20 mM phosphate buffer, pH 7.0 or in 20 mM
HEPES, pH 8.0).
Lipid bilayer measurements and single-channel analysis were
performed as described elsewhere [27–32]. Brieﬂy, a cell with a 40–60
μm diameter aperture in a 15-μm-thick Teﬂon partition provided a
two-compartment black lipid membrane (BLM) chamber and two
silver–silver chloride electrodes at either side of the dividing wall
allowed voltage control of solvent-free planar lipid bilayers that were
formed using a solution of DPhPC in pentane. Low levels of the study
BpsOmp38 channel were introduced to the cis or trans side of the
bilayers by adding the protein stock solution of about 1–2 μg/ml
containing 1% (v/v) octyl-POE (ALEXIS, Switzerland). In the trials
addressing the temperature dependence of drug translocation, a
peltier element (Dagan Corporation, Minneapolis, MN, USA) was used
for accurate temperature regulation of the BLM chamber. At an
applied transmembrane voltage of +50 mV, spontaneous channel
insertion was usually obtained within a few minutes after adding the
protein solution. Conductance measurements were performed using
an Axopatch 200B ampliﬁer (Molecular Devices, Sunnyvale, CA, USA)
in the voltage clamp mode and the internal ﬁlter at 10 kHz.
Amplitude, probability, and single-channel analyses were performed
using pClamp v.10.0 software (Molecular Devices). Control experi-
ments (refer to Supplementary S3, upper left recording) showed no
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the presence of the buffer alone.
Black lipid bilayer measurements with BpsOmp38 from an earlier
preparation with mass spectrometry (MS) identiﬁcation (Supple-
mentary S1) established that the single-channel conductance of the
targeted reconstituted protein channel is about 2.7±0.3 nS in 1 M
KCl. A channel of identical conductance also routinely appeared when
freshly formed solvent-free DPhPC bilayer membranes were exposed
to the protein prepared by the procedure described in the preceding
section. Accordingly, translocation of drug molecules was analyzed in
recordings of this particular channel. Another channel that frequently
incorporated during the BLM experiments was not used for the
translocation studies after its small conductance (0.3 nS in 1 M KCl)
and MS data suggested it was a maltoporin.2.3. Porin homology modeling
The structural model of recombinant BpsOmp38 was built based
upon the Modeller suite of programs [42]. Initially, several iterations
of the PSI-BLAST protein sequence search program in the pdb database
were performed to allow detection of remote homologues of the
BpsOmp38 porin. Only the templates with non-redundant structures
were kept and further used for building the homology model. Such
templates included the pdb codes 3K1B (OmpF), 2IXX (OmpC), 1E54
(Omp32), 1OSM (Ompk36) and 3A2R (PorB). A multiple-sequence
alignment revealed a complete coverage of the homology sequence,
although only about 24% sequence identity was observed between
the BpsOmp38 and the template amino acid residues. Fifty structural
models of the BpsOmp38 trimers were further generated by the
Modeller program, fromwhich the “representative model”was deﬁned
as the one that minimized both the overall ‘Modeller objective
function’ and the ‘Dope score evaluation function’. Finally, the “ﬁnal
best model” was assessed with the energetic based validation suite
ProQ [43] and the geometric based PROCHECK, with the latter showing
only 2.8% of Ramachandran disallowed regions and absence of close
(or “bad”) contacts.Fig. 1. Trimeric BpsOmp38 porin from Burkholderia pseudomallei. The recombinant protein w
isolated by sodium dodecyl sulfate-extraction and then solubilized by 1% (v/v) octyl-POE
electrophoresis analysis of recombinant BpsOmp38. Track 1: low molecular weight protein m
denaturing conditions; Track 3: BpsOmp38 subunit after denaturing condition at 100 °C fo
DPhPc membranes. A three-step closure was induced by increasing the applied voltage to +3. Results and discussion
We have previously reported the recombinant expression of
the BpsOmp38 gene in E. coli BL21 Origami (DE3) cells [36,37]. The
recombinant BpsOmp38 protein, which was in the form of inclusion
bodies, was further refolded into trimeric form using 10% (w/v)
ZwittergentTM 3-14. In the present study, the BpsOmp38 gene,
including a 20-amino acid signal peptide fragment, was subcloned
into a pET23d(+) vector so it could be incorporated and fully
expressed as a fully functional trimeric protein in the cell wall of the
mutant E. coli BL21 (DE3) Omp8 strain. After extraction by 2% SDS
and solubilization in 1% (v/v) octyl-POE, SDS–PAGE analysis demon-
strated migration of the extracted porin as a protein band with an
apparent MW of 100 kDa (Fig. 1A, lane 2). This was assumed to be the
trimeric form of BpsOmp38. Upon heat treatment at 100 °C for 10 min,
the presumed trimer was denatured and a new band with apparent
MW of 35 kDa appeared as expected for the BpsOmp38 monomer
(Fig. 1A, lane 3).
When BpsOmp38 was reconstituted in stable DPhPC lipid bilayers,
the study protein (porin) behaved like an ion channel and allowed a
speciﬁc current ﬂow under controlled voltage application. Single
trimeric BpsOmp38 units in the bilayer membrane showed a
characteristic conductance of 2.7±0.3 nS in 1 M KCl/20 mM HEPES
pH 8.0 but the channels were prone to close at high transmembrane
potentials (above ±100 mV). A typical membrane current recording
that was obtained for a single trimeric BpsOmp38 channel at an
elevated transmembrane potential of +150 mV is shown in Fig 1B.
Within the time span of a few seconds, the fully open BpsOmp38
channel changed sequentially by a three-step process into the fully
closed state. This process appeared as a three-stage decrease in
conductance signal and conﬁrmed once again the trimeric channel
organization that had already been suggested by the SDS–PAGE gel
analysis (Fig. 1A). The biological relevance of the successive closure of
the individual units of multimeric bacterial porins is poorly under-
stood, bearing in mind that, in vivo, the potential difference across the
bacterial outer membrane is usually negligible. On the other hand,
parameters such as pH, ion composition of the internal and externalas expressed in a mutant E. coli BL21 (DE3) Omp8 strain lacking major intrinsic porins,
in 1 M KCl/20 mM HEPES, pH 8.0. A. Sodium dodecyl sulphate–polyacrylamide gel
arkers (PageRuler, Fermentas Inc., USA); Track 2: intact BpsOmp38 trimers under non-
r 10 min. B. A single-channel recording of the BpsOmp38 reconstituted in solvent-free
150 mV.
Fig. 2. Kinetic analysis of antimicrobial agent translocation through BpsOmp38. A. Effect of
ertapenem concentrations. No blockage event was detected when a single trimeric
channel was recorded in the absence of antimicrobial agents, whereas complete blockage
events were observed as a direct proportion to increased concentrations of ertapenem
from2.5, 5, 7.5, and 10 mM.Here, only 5 and10 mMconcentrations are presented. B. Effect
of temperature. An increased number of blockage events were observed upon increases in
temperature from5, 10, 15, 20, 25, 30, 35, 40, and 45 °C. On the other hand, the dwell time
of ertapenem translocation decreased exponentially with increasing temperatures. Here,
only the BLM recordings at 5, 25 and 45 °C are presented. The single-channel recordings
were recorded at +100 mV. Similar ion blockage patterns were also seen with +50 mV
(not shown). C. Dwell time histogram. Ertapenem (10 mM) was added on the cis side of
the lipidmembranes. The average dwell timewas obtainedwhen the datawas ﬁtted using
the standard exponential curve ﬁt available in pClampﬁt v10.0.
Table 1
Kinetic analysis of antibiotic translocation through the BpsOmp38 channel.
Antibiotic kon (s−1 M−1) koff (s−1) K (M−1)
Penicillin G n.d.a n.d. n.d.
Meropenem 25 6700 0.004
Imipenem 150 6700 0.02
Cefepime 1300 5500 0.24
Ceftazidime 4200 7000 0.60
Ertapenem 8200 6900 1.2
Norﬂoxacin 300,000 10,000 30
a n.d. represents non-detectable event.
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potential and response to variations of these factors may contribute to
the physiological signiﬁcance of channel closing.
To study the translocation of drug molecules through the isolated
porin, a potential was applied across the incorporating lipid mem-
branes at which reconstituted BpsOmp38 channels predominantly
existed in their fully open state. Ion current blockages through the
open channels were then analyzed after applying the selected
antimicrobial agent to either the cis or trans side of the bilayer. Drug
translocation trials were performed with a set of antimicrobial agents
including three β-lactam antibiotics (penicillin G, meropenem,
imipenem), two cephalosporins (cefepime, ceftazidime), one ﬂuoro-
quinolone (norﬂoxacin) and one carbapenem (ertapenem) (refer to
Supplementary S2 for chemical structures). With the exception of
penicillin G, all the test antimicrobial agents interacted with the
BpsOmp38 channel in such a way that spontaneous fast ﬂuctuations of
the BLM membrane current were induced. Overall, the number of
current deﬂections in the recording of certain length varied linearly
with concentrations that were independent of the type of antibiotic
tested. Ertapenem, for example, produced a consistent response as
shown in Fig. 2A. In high-time resolution current recordings, theFig. 3. Arrhenius plots for the ertapenem translocation through BpsOmp38 protein
pores. A. The logarithmic values of the on-rate and off-rate constants obtained from
both cis and trans sides were plotted as a function of temperature. B. A diagram
representing symmetrical values of the energy barriers required for ertapenem
binding and releasing from most likely the identical afﬁnity site localized within the
BpsOmp38 pore.
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BpsOmp38 channel was well resolved. As previously suggested for
translocation measurements with other Omps [27–35], the observed
current deﬂections are taken to indicate the brief presence of anti-
biotic (in this case ertapenem) molecules within the porin channel
during the time of their passage, which consequently blocks the ion
ﬂux and thus decreases the membrane current. In the absence of
ertapenem, the stable open BpsOmp38 channel membrane currentFig. 4. The modeled structure of BpsOmp38 based on multiple templates. A. A multiple alig
selected templates was performed by SALIGN from theModeller suite of programs (see texts)
(Omp32); 1OSM (Ompk36); 3A2R (PorB), and the modeled structure of BpsOmp38 (Bps).
translocation of OmpF or OmpC (blue) and the substituted ones (red). Numbering of the BpsO
included here) (GenBank accession no: AY312416). B. A snapshot of the homology mode
illustrated by itsmolecular surface properties. Differences in the known key residues of OmpF
with the residues in “sticks” representation and colored green for polar, blue for positively ch
in cartoons in order to highlight its secondary-structure elements with the loop L3 coloredwas typically free of signiﬁcant ﬂuctuations. At a concentration of
5 mM, ertapenem consistently blocked one monomer of a single
trimeric channel for a fraction of a millisecond. Simultaneous block-
age of two of the three available monomers at a time became visible
at higher concentrations (e.g. 10 mM). A complete and simultaneous
blockade of all the three porin subunits was also infrequently
observed. For a given concentration of ertapenem, addition of the
antibiotic to the trans side of the BLM chamber led to about a two-foldnment of the BpsOmp38 sequence lacking the 22-amino-acid-signal peptide with the
. The pdb codes used as the homology templates are: 3K1B (OmpF); 2IXX (OmpC), 1E54
Highlights are the conserved residues known to be important for antimicrobial agent
mp38 residues follows the complete sequence containing the 20-aa-signal peptide (not
l of BpsOmp38 (top view). The lipid bilayer membrane inserted around the porin is
compared to the BpsOmp38 (corresponding to the alignment in Fig. 4A) are highlighted
arged, and red for negatively charged. The backbone of the BpsOmp38 porin is displayed
in orange.
Fig. 4 (continued).
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substrate was added to the cis side. Black lipid bilayer measurements
taken between 5 and 45 °C in the presence and absence of the
substrate demonstrated that temperature had a strong impact on the
rate of ertapenem translocation through the BpsOmp38 channel
(Fig. 2B). At non-physiologically low temperature of 5 °C, relatively
few membrane current blockages with rather long blocking times of
over 1 ms were observed. Increasing the temperature to 45 °C
elevated the frequency of current deﬂections while decreasing the
dwell time (τ) of the penetrating molecules. Average τ values for
deﬁned conditions in terms of temperature and concentration were
obtained through a statistical analysis of raw BLM data and a single-
exponential ﬁtting of blockage time histograms as shown in Fig. 2C
for ertapenem interaction with BpsOmp38 measured at 25 °C. The
average τ of ertapenem molecules inside the BpsOmp38 channel
decreased exponentially with increasing temperature, did not appear
to depend on the concentration of the antibiotic, nor was it inﬂuenced
by the side of the BLM chamber to which the antimicrobial agent was
added. Taken together, these observations support the existence of a
single afﬁnity site for the ertapenem molecules in the BpsOmp38
channel. The rates of channel entry and exit are critical factors in the
net ﬂux of an antibiotic through a bacterial Omp pore. The BLM-based
observation of the molecular interaction of ertapenem with the
BpsOmp38 channel at various temperatures and concentrations
allowed calculation of: i) the drug binding kinetics and the second-
order on-rate constant kon (M−1 s−1), ii) the ﬁrst-order off-rate
constant koff (s−1), and iii) the equilibrium binding constant K (the
ratio of kon/koff; M−1). Table 1 gives a comprehensive list of the three
parameters kon, koff and K for all seven antimicrobial agents whose
translocation through the BpsOmp38 channel was investigated in the
present study (refer to Supplementary S3 for blockage characteristics
of the ion ﬂow through BpsOmp38 by representatives of each class
of the antimicrobial agents). Note that ion blockage by ertapenem
applied to the cis side of the lipid membrane at a transmembrane
potential +100 mV occurred with kon=8200 M−1 s−1 and a bindingconstant of about 1.2 M−1. These values reasonably agree with
those for the interaction of ertapenem with the major Enterobacter
aerogenes Omp36 [30]. Furthermore, the off-rates did not vary
signiﬁcantly for this panel of antimicrobial agents, while a ranking
of kon and K saw the three β-lactam antibiotics with rather low
values that were clearly at the bottom end, the two cephalosporin
drugs at the middle, and carbapenem and ﬂuoroquinolone antibi-
otics at top positions. Greater values of kon and K indicated that
translocation of the newer class of drugs through the BpsOmp38
pore took place more rapidly.
Temperature dependence measurements were used to calculate
the free energy proﬁle of transporin antibiotic permeation. For
ertapenem, the effective energy barriers (E) to reach and cross the
internal binding site of a BpsOmp38 channel from the cis (Eon,cis) or
trans (Eon,trans) side of the bilayer were estimated from the typical
Arrhenius plots (Fig. 3A). The analysis of the relevant plots revealed
that effective energy barriers Eon,cis and Eon,trans, representing the
binding of ertapenem to the afﬁnity site of a BpsOmp38 protein pore
at +100 mV transmembrane voltage, were estimated to be 12 kT. The
Arrhenius plots for the off rates, which allowed calculation of the
effective energy barriers Eoff,cis and Eoff,trans for the ertapenem release
from the afﬁnity site of the BpsOmp38 channel at +100 mV, were
13 kT (see Fig. 3B). Estimation of symmetrical values of the energy
barriers required for ertapenem binding and release from cis-to-trans
side and from trans-to-cis side further supports a single afﬁnity site
inside the BpsOmp38 channel as earlier on suggested.
The homology model of the porin BpsOmp38 was built based on
ﬁve different templates obtained from homologous Gram-negative
bacterial porins with non-redundant structures (refer to Materials
and methods). Despite an observed low-sequence identity (~24%),
the overall fold of the generated BpsOmp38 trimers was found to be
conserved. The alignment in Fig. 4A shows that the target sequence is
completely covered by the different templates and that a few
insertions and deletions are all found in the extracellular loops except
for the small protrusion of a four-residue loop in the middle of the
1558 W. Suginta et al. / Biochimica et Biophysica Acta 1808 (2011) 1552–1559second strand of each monomer (see Fig. 4B). This small protrusion
was also reported in the previously characterized Omp32 [44].
The BpsOmp38 model was compared with the structure of the
porin OmpF, for which the structure–function relationship of antibiotic
translocation has been extensively studied [34]. Compared with OmpF,
however, the amino acid sequences of various regions that participate
in pore-forming properties were found to be different. These include
the L3 loop that forms the constriction region of the channel, the
arginine residues at the mouth of the OmpF channel, and the basic
cluster in the anti-L3 side. In the case of the BpsOmp38 channel, more
acidic residues are observed instead in such regions. Within the known
key residues of OmpF that were aligned with BpsOmp38, segments
with conserved or amino acid substitutions are highlighted as shown
in Fig. 4A.
Fig. 4B is a graphic representation of the modeled BpsOmp38
trimeric structure, when incorporated into phospholipid bilayer mem-
branes. Highlights indicate an obstructing internal protrusion, aswell as
the polar to acidic character of certain channel wall residues that point
towards the lumen of the pore. It is predictable that the substitutions
from OmpF to BpsOmp38 of the residues: K16V29, V20D31, K80F108,
D113S130, F118W135, R167N187, andR168N188mayhave aneffect on
drug transport through the BpsOmp38 porin (see Fig. 4B). However, this
hypothesis has to be conﬁrmed by a combined approach, including
microbiological assays, site-directed mutations and biophysical mea-
surements, together with molecular dynamic simulations of antibiotic
transport as previously described for OmpF [34,35].
In conclusion, the present study demonstrates, for the ﬁrst time, the
ion-channel properties of theoutermembraneporin BpsOmp38derived
from the highly virulent and drug resistant bacterium B. pseudomallei.
High-time resolution analysis of different classes of antimicrobial agents
provided initial insights into the transport mechanisms of antimicro-
bial agents through the BpsOmp38 channel. We highly recommend
further studies that base on thoughtfully genetically engineered
BpsOmp38 and those that exploit joint applications of structural, func-
tional and computational assays to develop highly efﬁcacious drugs
against clinical melioidosis.
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